Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 186,587 | 98,013 | 103,670 | 46,667 | 41,813 |
| Marketable Securities | 8,879 | 8,617 | 8,091 | 5,627 | 3,637 |
| TOTAL | $196,203 | $107,894 | $112,650 | $52,821 | $45,710 |
| Non-Current Assets | |||||
| PPE Net | 5,961 | 4,354 | 3,014 | 1,632 | 256 |
| Other Non-Current Assets | 2,992 | 3,456 | 452 | 0 | 64 |
| TOTAL | $8,953 | $7,810 | $3,466 | $1,632 | $320 |
| Total Assets | $205,156 | $115,704 | $116,116 | $54,453 | $46,030 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 896 | 1,126 | 888 | 378 | 214 |
| Accrued Expenses | 2,606 | 1,698 | 1,708 | 1,538 | 545 |
| TOTAL | $3,940 | $3,242 | $2,596 | $1,916 | $759 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,926 | 2,976 | 294 | 245 | 0 |
| TOTAL | $2,926 | $2,976 | $294 | $245 | $N/A |
| Total Liabilities | $6,866 | $6,218 | $2,890 | $2,161 | $759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,300 | 14,444 | 14,431 | 14,429 | 10,354 |
| Retained earnings | -29,418 | -24,070 | -19,959 | -16,251 | -13,496 |
| Other shareholders' equity | 18 | 16 | 2 | 1 | -2 |
| TOTAL | $198,290 | $109,486 | $113,226 | $52,292 | $45,271 |
| Total Liabilities And Equity | $205,156 | $115,704 | $116,116 | $54,453 | $46,030 |